Bio Key International (BKYI) Invested Capital (2012 - 2026)

Bio Key International has reported Invested Capital for 9 years, with the latest figure at $651935.0 in Q1 2026.

• Quarterly Invested Capital rose 370.14% year-over-year to $651935.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (down 7.75% YoY) and the FY2025 annual result came in at $604102.0, down 60.41% from the prior year.
• Invested Capital grew to $651935.0 in Q1 2026 per BKYI's latest filing, from $604102.0 in the prior quarter.
• Over five years, Invested Capital peaked at $2.6 million in Q4 2022 and troughed at $88115.0 in Q3 2025.
• A 5-year average of $882968.2 and a median of $500000.0 in 2022 frame the typical range for Invested Capital.
• The widest YoY moves for Invested Capital: up 1948.18% in 2023, down 94.66% in 2023.
• Over 5 years, Invested Capital stood at $2.6 million in 2022, then sank by 94.66% to $138730.0 in 2023, then surged by 999.96% to $1.5 million in 2024, then sank by 60.41% to $604102.0 in 2025, then gained by 7.92% to $651935.0 in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $651935.0, $604102.0, and $88115.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.